Variant report
Variant | esv3496912 |
---|---|
Chromosome Location | chr6:63541042-63598293 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536193684 | chr6:63541110-63541111 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570479898 | chr6:63541126-63541127 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534697519 | chr6:63541146-63541147 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548058408 | chr6:63541149-63541150 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566563326 | chr6:63541152-63541153 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533899768 | chr6:63541157-63541158 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184850463 | chr6:63541178-63541179 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143442251 | chr6:63541181-63541182 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375632118 | chr6:63541200-63541201 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs9343268 | chr6:63541210-63541211 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs188338304 | chr6:63541219-63541220 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575179127 | chr6:63541223-63541224 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545641574 | chr6:63541226-63541227 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147131784 | chr6:63541267-63541268 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577300880 | chr6:63541281-63541282 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541486626 | chr6:63541298-63541299 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577225192 | chr6:63541326-63541327 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559490555 | chr6:63541337-63541338 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530074792 | chr6:63541342-63541343 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542234020 | chr6:63541348-63541349 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78781880 | chr6:63541349-63541350 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531205963 | chr6:63541350-63541351 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs180771035 | chr6:63541359-63541360 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373536902 | chr6:63541380-63541381 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144285589 | chr6:63541410-63541411 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546629061 | chr6:63541444-63541445 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567975947 | chr6:63541455-63541456 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535123102 | chr6:63541464-63541465 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550157989 | chr6:63541538-63541539 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568840207 | chr6:63541569-63541570 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539333411 | chr6:63541621-63541622 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557684476 | chr6:63541655-63541656 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4566867 | chr6:63541665-63541666 | Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs144363400 | chr6:63541709-63541710 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148772411 | chr6:63541717-63541718 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574983185 | chr6:63541728-63541729 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542268792 | chr6:63541804-63541805 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76358172 | chr6:63541806-63541807 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576021578 | chr6:63541831-63541832 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546446872 | chr6:63541835-63541836 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564530312 | chr6:63541873-63541874 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35466764 | chr6:63541882-63541883 | Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs546871762 | chr6:63541906-63541907 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34903790 | chr6:63541907-63541908 | Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs184828976 | chr6:63541944-63541945 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs55767251 | chr6:63541960-63541961 | Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs568480237 | chr6:63541962-63541963 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539350332 | chr6:63542000-63542001 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4310033 | chr6:63542028-63542029 | Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs566645100 | chr6:63542035-63542036 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:63541000-63543000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:63541400-63542200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr6:63543000-63544600 | Genic enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:63544600-63545800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:63545800-63556600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:63556600-63560400 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr6:63560400-63561800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:63561800-63563000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:63563000-63572400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr6:63571800-63572400 | ZNF genes & repeats | Monocytes-CD14+_RO01746 | blood |
11 | chr6:63572400-63572600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:63572600-63579600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:63579600-63582400 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:63582400-63589200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr6:63589200-63591800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr6:63591800-63596800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr6:63594000-63595200 | Enhancers | A549 | lung |
18 | chr6:63595200-63599200 | Weak transcription | A549 | lung |
19 | chr6:63596800-63597800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr6:63597800-63598200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr6:63598200-63603800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |